Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.



On February 18, 2021, the Compensation Committee (the "Committee") of the Board
of Directors of GenMark Diagnostics, Inc. (the "Company") adopted the 2021 Bonus
Plan, which provides for the payment to eligible employees, including the
Company's named executive officers ("NEOs"), of cash incentive compensation for
the 2021 calendar year performance period. The Compensation Committee
established a target bonus under the 2021 Bonus Plan for the Company's CEO equal
to 100% of his annual base salary, and established a target bonus for each of
the Company's other NEOs equal to 50% of their respective 2021 base salaries.
Bonuses payable under the 2021 Bonus Plan are based on certain financial and
operational goals as approved by the Compensation Committee. Based on actual
performance, a participant in the 2021 Bonus Plan may receive between 0% and
150% of his or her target bonus amount under the 2021 Bonus Plan. The foregoing
description of the 2021 Bonus Plan is only a summary, does not purport to be
complete, and is qualified in its entirety by reference to the full text of the
2021 Bonus Plan, a copy of which is filed hereto as Exhibit 10.1.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.

Exhibit Number              Description
10.1*                       The GenMark Diagnostics, Inc. 2021 Bonus Plan
104                         Cover Page Interactive Data File (embedded

within the Inline XBRL document)

* Indicates a management contract or compensatory plan or arrangement in which any

director or named executive officer participates.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses